Primus Lifesciences Private Limited
About Primus Lifesciences Private Limited
Data last updated:
Primus Lifesciences Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 28 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2015PTC035128. Its GSTIN is 23AAICP4330K1ZH (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinod Kumar Amrute and Pramod Amrute.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H. No. Lig 537 Phase 5 Part 2 Housing Board Colony Ayodhya Nagar, Bhopal, Madhya Pradesh, India – 462041.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.06 Lakh, a decline of 35% compared to the previous year. For the same year it recorded a net loss of ₹81,357 (net margin -39.6%) and EBITDA of -₹81,030 (EBITDA margin -39.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Primus Lifesciences Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH. No. Lig 537 Phase 5 Part 2 Housing Board Colony Ayodhya Nagar, Bhopal, Madhya Pradesh, India – 462041
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Primus Lifesciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Primus Lifesciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Primus Lifesciences Private Limited, buy the company report.
Financials of Primus Lifesciences Private Limited
FY 2024 filings availablePrimus Lifesciences Private Limited reported revenue of ₹2.06 Lakh (down 35% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 35% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹81,030 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹81,357 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -39.4% | ||||
| Net Profit Margin | -39.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Primus Lifesciences Private Limited, buy the company report.
Board of directors of Primus Lifesciences Private Limited
Primus Lifesciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinod Kumar Amrute | Director | 28 Dec 2015 | 10 Years 10 Months | Current |
| Pramod Amrute | Director | 28 Dec 2015 | 10 Years 10 Months | Current |
Auditor
Primus Lifesciences Private Limited is audited by ALI JAIN & SHARMA for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ALI JAIN & SHARMA | FY 2020 | 015831C |
Shareholding
The shareholding of Primus Lifesciences Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Primus Lifesciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Primus Lifesciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Primus Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Primus Lifesciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAICP4330K1ZH | Madhya Pradesh | Active | 01 Apr 2019 |
To see the full GST registrations and return filing status of Primus Lifesciences Private Limited, buy the company report.
Recent activity
Primus Lifesciences Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Pramod Amrute was appointed as Director on 28 Dec 2015.
Frequently asked questions
Primus Lifesciences is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in wholesale, within the trading industry. It was incorporated on 28 December 2015 (11+ years old) and is registered under CIN U51909MP2015PTC035128.
Primus Lifesciences has 2 current directors:
- Vinod Kumar Amrute - Director
- Pramod Amrute - Director
The latest financial statements of Primus Lifesciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Primus Lifesciences is 23AAICP4330K1ZH, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Primus Lifesciences is U51909MP2015PTC035128. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Primus Lifesciences was incorporated on 28 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Gwalior.
Pramod Amrute was appointed as Director on 28 Dec 2015. Vinod Kumar Amrute was appointed as Director on 28 Dec 2015.
The registered office of Primus Lifesciences is at H. No. Lig 537 Phase 5 Part 2 Housing Board Colony Ayodhya Nagar, Bhopal, Madhya Pradesh, India – 462041.
Primus Lifesciences operates in the trading industry, in the wholesale segment.
The compliance status of Primus Lifesciences is compliant as of 10 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
